This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Designing an IHC experiment for Mastermind-like protein 2? The guide has the expected staining pattern, antigen retrieval and fixation, antibodies backed by real IHC images, the tissue controls to run alongside, and protocols taken from published papers.
Open the MAML2 IHC GuideFacts about Mastermind-like protein 2.
Potentiates activation by NOTCH3 and NOTCH4 Better than MAML1 or MAML3. .
| Human | |
|---|---|
| Gene Name: | MAML2 |
| Uniprot: | Q8IZL2 |
| Entrez: | 84441 |

| Belongs to: |
|---|
| mastermind family |

DKFZp686N0150; KIAA1819MGC176701; MAM2; mam-2; MAM-3; MAM3MLL-MAML2; mastermind (Drosophila)-like 2; mastermind-like 2 (Drosophila); mastermind-like protein 2
Mass (kDA):
125.197 kDA

| Human | |
|---|---|
| Location: | 11q21 |
| Sequence: | 11; NC_000011.10 (95976598..96343308, complement) |
Widely expressed with high levels detected in placenta, salivary gland and skeletal muscle.
Nucleus speckle. Nuclear, in a punctate manner.




PMID: 12539049 by Tonon G., et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.
PMID: 14720503 by Enlund F., et al. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors.